ABBEY CARROLL: Open Payments
NPI 1457114043 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $148 · 2025 $617
Food & beverage: $413Education: $204
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $221 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| ABBVIE INC. | 5 | $94 |
| Alkermes, Inc. | 4 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
Products named: REXULTI, VRAYLAR, ARISTADA, CAPLYTA, Auvelity, SPRAVATO, COBENFY, UZEDY.
Industry payments across CO — which companies pay providers there.
